Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study

Kenji Kabashima, Masutaka Furue, Jon M. Hanifin, Grazyna Pulka, Andreas Wollenberg, Ryszard Galus, Takafumi Etoh, Ryosuke Mihara, Miwa Nakano, Thomas Ruzicka

Research output: Contribution to journalArticlepeer-review

158 Scopus citations

Fingerprint

Dive into the research topics of 'Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study'. Together they form a unique fingerprint.

Medicine & Life Sciences